Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy

By Criscitiello Carmen   Gelao Lucia   Viale Giulia   Esposito Angela   Curigliano Giuseppe  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 599-610

Informa Healthcare

Access to resources Recommend Favorite

Platelet-derived growth factor receptor tyrosine kinase inhibitors: a review of the recent patent literature

By Dai Yujia  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 7, 2010-07 ,pp. : 885-897

Informa Healthcare

Access to resources Recommend Favorite

Beneficial Effects of a Novel Inhibitor of Platelet-Derived Growth Factor Receptor Autophosphorylation in the Rat with Mesangial Proliferative Glomerulonephritis - evidence for a model of intramolecular allosteric activation

By Yagi M.   Kato S.   Kobayashi Y.   Kobayashi N.   Iinuma N.   Nakamura K.   Kubo K.   Ohyama S.-I.   Murooka H.   Shimizu T.   Nishitoba T.   Osawa T.   Nagano N.  

General Pharmacology, Vol. 31, Iss. 5, 1998-11 ,pp. : 765-773

Elsevier

Access to resources Recommend Favorite

Tyr⁷⁴⁰ and Tyr⁷⁵¹ residues of platelet-derived growth factor beta receptor are responsible for the redox regulation of phosphatase and tensin homolog in the cells stimulated with platelet-derived growth factor

By Kim Inyoung   Han Seong-Jeong   Kim Yujeong   Ahn Younghee   Chay Kee-Oh   Lee Seung-Rock  

Redox Report, Vol. 16, Iss. 4, 2011-07 ,pp. : 181-186

Maney Publishing

Access to resources Recommend Favorite

Endothelin ET A receptor antagonist reverses the inhibitory effect of platelet-derived growth factor on cytokine-induced nitric oxide production

By Hirahashi J.   Nakaki T.   Hishikawa K.   Marumo T.   Hayashi M.   Saruta T.  

European Journal of Pharmacology, Vol. 365, Iss. 1, 1999-01 ,pp. : 119-123

Elsevier

Access to resources Recommend Favorite